country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

製品番号: HY-P1699

Copy Link Print Information

Aurantimycin A

Aurantimycin A is a pore-forming antibacterial agent. Aurantimycin A has activity against Gram-positive bacteria, including Bacillus subtilis and Listeria monocytogenes, but has no activity against Gram-negative bacteria or fungi. Aurantimycin A can be used in research related to bacterial infections.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号: 162478-50-4
分子式: C₃₈H₆₄N₈O₁₄
分子量:856.96

保管条件:

Please store the product under the recommended conditions in the Certificate of Analysis.

Aurantimycin A 構造式

CAS 番号: 162478-50-4

価格（税別）

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

生物活性

製品説明

体外実験

Bacterial InfectionFungal InfectionOthers

Bacterial Infection

Aurantimycin A shows an MIC of 1.28 µg/mL in B. subtilis BSAH1 after xylose-induced expression of lieAB^[4].

Bacterial Infection

Fungal Infection

Aurantimycin A (compound 1) (0.007-0.08 μg/mL; 18 h (bacteria); 42 h (fungi)) inhibits Gram-positive bacteria with MICs ranging from 0.007 to 0.08 μg/mL, and is inactive against Gram-negative bacteria and fungi at MIC >>100 μg/mL^[5].

Others

Aurantimycin A (compound 1) increases the conductivity of soybean phosphatidylcholine black lipid membranes in a concentration-dependent manner and forms membrane pores at concentrations above 0.1 µM^[1].
Aurantimycin A (compound AA) (4 h) antagonizes 5-HT- and histamine-induced contraction of guinea pig tracheal rings, with IC₅₀ values of 0.50 μM and 1.96 μM, respectively^[3].
Aurantimycin A (48-72 h) is cytotoxic to L-929 mouse fibroblasts, with an IC₅₀ of 7 ng/mL^[5].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Related Protocols :

化学情報

CAS 番号 162478-50-4
分子量 856.96
分子式 C₃₈H₆₄N₈O₁₄
輸送条件

Room temperature in continental US; may vary elsewhere.
保管条件

Please store the product under the recommended conditions in the Certificate of Analysis.

純度とドキュメンテーション

バッチを選択:

純度: 99.98%

Assay: 99.98%

ee.: 99.98%

データシート (281 KB)
SDS (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
COA (2659 KB)
元素分析報告書 (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
取扱説明書 (2659 KB)

参考文献

[1]. Grigoriev P, et al. Formation of membrane pores by aurantimycins A and B, new lipopeptide antibiotics from Streptomyces aurantiacus. Bioelectrochemistry and Bioenergetics. 1995;36:57-59.

[2]. Engelgeh T, et al. ClpP2 proteasomes and SpxA1 determine Listeria monocytogenes tartrolon B hyper-resistance. PLoS genetics. 2025 Apr;21(4):e1011621.

[3]. Assem EK, et al. Pharmacological actions of a new synthetic cyclodepsipeptide, the A83586C-citropeptin hybrid, on complement C5a and G-Proteins. Inflammation Research. 2008 Apr 1;57:21.

[4]. Hauf S, et al. Elements in the LftR Repressor Operator Interface Contributing to Regulation of Aurantimycin Resistance in Listeria monocytogenes. Journal of bacteriology. 2021 Apr 21;203(10):e00503-20.

[5]. Gräfe U, et al. Aurantimycins, New Depsipeptide Antibiotics from Streptomyces Aumntiacus IMET 43917 Production, Isolation, Structure Elucidation, and Biological Activity. The Journal of antibiotics. 1995 Feb 25;48(2):119-25. [Content Brief]

Calculators

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

お問い合わせ在庫あり

Other size

お問い合わせ